Cardiac mapping is a technique in which the information from cardiac electrograms is gathered and displayed. Cardiac mapping is used to diagnose the heart rhythms especially in case of arrhythmia. The cardiac mapping procedure is usually done by inserting catheter into the heart chamber percutaneously and recording the electrograms sequentially, this is done in order to correlate the electrograms with cardiac anatomy. The new 3D cardiac mapping systems create the three dimensional model of any chamber of heart and can track exact location of the catheter. This allows movement of the catheters without using X-ray. They are designed to improve the resolution and gain prompt cardiac activation maps.
Scope of the Report:
This report studies the 3D Cardiac Mapping System market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the 3D Cardiac Mapping System market by product type and applications/end industries.
The 3D cardiac mapping system market is anticipated to grow with a significant CAGR owing to the increase in number of patients with arrhythmia and other cardiac disorders, rising pressure to reduce diagnosis errors and increasing healthcare expenditure. The major factors driving the growth of 3D cardiac mapping systems is the precision and patient safety enabled by real-time monitoring. The increase in aging population who are more prone to chronic heart disorders will elevate the demand for the 3D cardiac mapping system. The increase in prevalence and diagnosis rate of cardiac illness is the major factors which is creating the demand for 3D cardiac mapping systems. The 3D cardiac mapping also help in reducing the time of diagnosis. The restraining factors for the 3D cardiac mapping system market are high cost of services and limited adoption rate of the systems.
North America contributes maximum share to the 3D cardiac mapping system market. European countries are expected to represent significant growth rates due to the growing healthcare practices. Amongst the Asian countries, India and China are more promising due to large population pool, increased prevalence of cardiac diseases, increasing awareness, rapid improvement in healthcare services with the saturation in the developed markets.
The global 3D Cardiac Mapping System market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of 3D Cardiac Mapping System.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Biosense Webster
St. Jude Medical
Boston Scientific Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Electroanatomical Mapping
Basket Catheter Mapping
Real-Time Positional Management (Cardiac Pathways) EP System
Market Segment by Applications, can be divided into
Hospitals
Clinics
Diagnostic Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 3D Cardiac Mapping System Market Overview
1.1 Product Overview and Scope of 3D Cardiac Mapping System
1.2 Classification of 3D Cardiac Mapping System by Types
1.2.1 Global 3D Cardiac Mapping System Revenue Comparison by Types (2017-2023)
1.2.2 Global 3D Cardiac Mapping System Revenue Market Share by Types in 2017
1.2.3 Electroanatomical Mapping
1.2.4 Basket Catheter Mapping
1.2.5 Real-Time Positional Management (Cardiac Pathways) EP System
1.3 Global 3D Cardiac Mapping System Market by Application
1.3.1 Global 3D Cardiac Mapping System Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Global 3D Cardiac Mapping System Market by Regions
1.4.1 Global 3D Cardiac Mapping System Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) 3D Cardiac Mapping System Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) 3D Cardiac Mapping System Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 3D Cardiac Mapping System Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) 3D Cardiac Mapping System Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) 3D Cardiac Mapping System Status and Prospect (2013-2023)
1.5 Global Market Size of 3D Cardiac Mapping System (2013-2023)
2 Manufacturers Profiles
2.1 Biosense Webster
2.1.1 Business Overview
2.1.2 3D Cardiac Mapping System Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Biosense Webster 3D Cardiac Mapping System Revenue, Gross Margin and Market Share (2016-2017)
2.2 St. Jude Medical
2.2.1 Business Overview
2.2.2 3D Cardiac Mapping System Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 St. Jude Medical 3D Cardiac Mapping System Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boston Scientific Corporation
2.3.1 Business Overview
2.3.2 3D Cardiac Mapping System Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boston Scientific Corporation 3D Cardiac Mapping System Revenue, Gross Margin and Market Share (2016-2017)
3 Global 3D Cardiac Mapping System Market Competition, by Players
3.1 Global 3D Cardiac Mapping System Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 3D Cardiac Mapping System Players Market Share
3.2.2 Top 10 3D Cardiac Mapping System Players Market Share
3.3 Market Competition Trend
4 Global 3D Cardiac Mapping System Market Size by Regions
4.1 Global 3D Cardiac Mapping System Revenue and Market Share by Regions
4.2 North America 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
4.3 Europe 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
4.5 South America 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
5 North America 3D Cardiac Mapping System Revenue by Countries
5.1 North America 3D Cardiac Mapping System Revenue by Countries (2013-2018)
5.2 USA 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
5.3 Canada 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
5.4 Mexico 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
6 Europe 3D Cardiac Mapping System Revenue by Countries
6.1 Europe 3D Cardiac Mapping System Revenue by Countries (2013-2018)
6.2 Germany 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
6.3 UK 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
6.4 France 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
6.5 Russia 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
6.6 Italy 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
7 Asia-Pacific 3D Cardiac Mapping System Revenue by Countries
7.1 Asia-Pacific 3D Cardiac Mapping System Revenue by Countries (2013-2018)
7.2 China 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
7.3 Japan 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
7.4 Korea 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
7.5 India 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
8 South America 3D Cardiac Mapping System Revenue by Countries
8.1 South America 3D Cardiac Mapping System Revenue by Countries (2013-2018)
8.2 Brazil 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
8.3 Argentina 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
8.4 Colombia 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue 3D Cardiac Mapping System by Countries
9.1 Middle East and Africa 3D Cardiac Mapping System Revenue by Countries (2013-2018)
9.2 Saudi Arabia 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
9.3 UAE 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
9.4 Egypt 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
9.5 Nigeria 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
9.6 South Africa 3D Cardiac Mapping System Revenue and Growth Rate (2013-2018)
10 Global 3D Cardiac Mapping System Market Segment by Type
10.1 Global 3D Cardiac Mapping System Revenue and Market Share by Type (2013-2018)
10.2 Global 3D Cardiac Mapping System Market Forecast by Type (2018-2023)
10.3 Electroanatomical Mapping Revenue Growth Rate (2013-2023)
10.4 Basket Catheter Mapping Revenue Growth Rate (2013-2023)
10.5 Real-Time Positional Management (Cardiac Pathways) EP System Revenue Growth Rate (2013-2023)
11 Global 3D Cardiac Mapping System Market Segment by Application
11.1 Global 3D Cardiac Mapping System Revenue Market Share by Application (2013-2018)
11.2 3D Cardiac Mapping System Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global 3D Cardiac Mapping System Market Size Forecast (2018-2023)
12.1 Global 3D Cardiac Mapping System Market Size Forecast (2018-2023)
12.2 Global 3D Cardiac Mapping System Market Forecast by Regions (2018-2023)
12.3 North America 3D Cardiac Mapping System Revenue Market Forecast (2018-2023)
12.4 Europe 3D Cardiac Mapping System Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific 3D Cardiac Mapping System Revenue Market Forecast (2018-2023)
12.6 South America 3D Cardiac Mapping System Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa 3D Cardiac Mapping System Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure 3D Cardiac Mapping System Picture
Table Product Specifications of 3D Cardiac Mapping System
Table Global 3D Cardiac Mapping System and Revenue (Million USD) Market S